The poplar bark beetle Trypophloeus binodulus (Coleoptera: Scolytidae) is a key pest of poplar trees (Malpighiales: Salicaceae, genus Populus) across northern Spain. However, among the more than 200 poplar clones available on the market, the clone USA 184-411 has the highest susceptibility to T. binodulus attacks. We tested the hypothesis that compounds released by the most susceptible poplar clone chemically mediate Trypophloeus binodulus behavior. The leaf and bark volatile chemical profile composition of host poplar Populus nigra L. (Salicaceae) clones were analyzed and tested on adult T. binodulus by electroantennography (EAG) and by monitoring their populations in baited traps in northern Spain. The collection of volatiles released by the leaves and bark of both clones by SPME revealed the emission of 53 components from different chemical classes. Salicylaldehyde dominated these collections of leaf volatiles and was more abundant in aerations of the more susceptible poplar clone (USA 184-411). The EAG response of adult beetles to salicylaldehyde was higher than that of any other plant odorants. In field trials, traps baited with salicylaldehyde + ethanol significantly captured more adults than all other treatments, irrespective of other lure components. The present study could aid in developing semiochemical-based management tactics against this important pest.
15 January 2026 in ACS Applied Materials & Interfaces
Combining additive-free solution processing of MXenes with template-assisted transfer represents an innovative approach for the fabrication of electrochemical sensors. Herein, we introduce a wax-assisted templating and stamp-transfer (WAST) approach to fabricate monolithic MXene transducers. To this end, two configurations were developed: (A) MXene-at-all electrodes, where the working, counter, and reference electrodes were entirely composed of MXene, and (B) MXene working electrodes combined with an Ag/AgCl pseudoreference and carbon counter electrodes. Additive-free MXene inks, at different concentrations and volumes, were filtered onto wax-templated PVDF membranes to form stampable patterns. Voltammetric characterization revealed consistent anodic and cathodic peak currents (Ipa and Ipc) and steady peak-to-peak separation (ΔEp) across three independent batches, indicating excellent reproducibility with Ipa = 87.9 ± 1.7 μA, Ipc = -81.3 ± 1.5 μA, and ΔEp = 255.9 ± 4.6 mV for configuration A, and Ipa = 43.8 ± 0.6 μA, Ipc= -62.8 ± 1.2 μA, with a 3-fold lower peak separation (ΔEp = 87.6 ± 0.9 mV) in the case of configuration B (mean ± SE, n = 15). Primary benchmarking with similar commercial systems signifies the efficacy of WAST-produced transducers to mimic commercial electrode performance and provides a robust alternative to conventional deposition methods. In addition, a proof-of-concept experiment for Hg2+ ion sensing validated its potential for practical applications. The WAST method offers a robust fabrication, configuration choice, and tool-light patterning that can accelerate lab-scale prototyping of stand-alone flexible electrochemical devices.
Neuroblastoma, a leading cause of cancer‐related mortality in early childhood, relies on anti‐GD2 immunotherapy, whose efficacy is critically dependent on systemic drug exposure that remains largely unmonitored in real time, limiting treatment optimization and early response assessment. Here, a first‐in‐class, label‐free electrochemical biosensing platform is reported for the direct quantification of naxitamab in patient‐derived samples. The system is based on a laser‐assisted reduced graphene oxide–gold nanoparticle (rGO@AuNPs) nanocomposite, enabling ultrasensitive detection through quantum capacitance modulation arising from perturbations in the electronic density of states of graphene upon biomolecular recognition. Laser‐assisted fabrication yields nanostructured electrodes with enhanced surface area and conductivity, promoting stable antibody immobilization and reproducible signal transduction. The platform operates in the femtomolar regime, with a linear response between 25 and 300 fM, high specificity against relevant interferents, and robust performance in diluted human serum. A single‐point calibration strategy enables accurate quantification while compensating for device variability. Application to retrospective clinical samples reveals distinct post‐infusion concentration profiles, enabling early discrimination between responder groups and detection of antidrug antibody development. This work establishes quantum‐capacitance biosensing as a generalizable strategy for real‐time monitoring of therapeutic antibodies in precision oncology.